INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Medable Beats Forecasted FPI Date While Raising eCOA Adherence In Japan
A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. See how they accomplished it and more with this case study.
-
eCOA Standards And KPIs To Include In Your Next RFI
Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.
-
Should Sponsors Provide Source Document Templates?
Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.
-
Early Phase Oncology Site Network: Benefits Of A Personal Touch
Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.
-
The State Of eSource Adoption In Clinical Trials5/12/2026
Learn how eSource-ready sites are improving trial efficiency, reducing site burden, and becoming essential to modern clinical trial execution.
-
Top 3 Tips For Choosing The Right Oncology CRO5/14/2025
From complex study designs and evolving regulations to time-sensitive treatment protocols, advancing oncology clinical trials present significant challenges for investigators, sites, and patients.
-
Paperless Online Remote Source Document Verification2/2/2026
Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
-
Delivering Successful Cell And Gene Therapy Trials9/10/2025
Successfully executing complex cell and gene therapy trials hinges on meticulous operational strategies and a patient-centric approach.
-
Phase 1 Trial In Painful Diabetic Peripheral Neuropathy2/24/2026
A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Integrate data from all industry sources to confidently plan budgets for studies worldwide, across all phases and therapeutic areas.
-
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
-
Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
-
eClinicalGPS is designed to automate and streamline clinical site payments, getting sites paid faster and more accurately with less administrative burden. Configured
-
TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.